Table 1 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results

<p>Patient demographics and tumor characteristics at baseline and at surgery, by randomized treatment group.</p>

Saved in:

Bibliographic Details
Main Author:	Nigel Bundred (15046233) (author)
Other Authors:	Nuria Porta (15029895) (author), Adrian Murray Brunt (15046236) (author), Angela Cramer (5870894) (author), Andrew Hanby (25460) (author), Abeer M. Shaaban (15046239) (author), Emad A. Rakha (7957955) (author), Anne Armstrong (15045410) (author), Ramsey I. Cutress (15046242) (author), David Dodwell (15046245) (author), Marie A. Emson (15046248) (author), Abigail Evans (7421527) (author), Sue M. Hartup (15046251) (author), Kieran Horgan (15030513) (author), Sarah E. Miller (15046254) (author), Stuart A. McIntosh (11368948) (author), James P. Morden (7594370) (author), Jay Naik (15046257) (author), Sankaran Narayanan (15046260) (author), Jane Ooi (15046263) (author), Anthony I. Skene (15046266) (author), David A. Cameron (6277425) (author), Judith M. Bliss (8827107) (author)
Published:	2025
Subjects:	Cancer Cancer Detection and Diagnosis Clinical Research and Trials Biomarkers Prognostic biomarkers Breast Cancer Clinical Trial Results Phase II clinical trials Precision Medicine
Tags:	Add Tag No Tags, Be the first to tag this record!

_version_	1849927635062226944
author	Nigel Bundred (15046233)
author2	Nuria Porta (15029895) Adrian Murray Brunt (15046236) Angela Cramer (5870894) Andrew Hanby (25460) Abeer M. Shaaban (15046239) Emad A. Rakha (7957955) Anne Armstrong (15045410) Ramsey I. Cutress (15046242) David Dodwell (15046245) Marie A. Emson (15046248) Abigail Evans (7421527) Sue M. Hartup (15046251) Kieran Horgan (15030513) Sarah E. Miller (15046254) Stuart A. McIntosh (11368948) James P. Morden (7594370) Jay Naik (15046257) Sankaran Narayanan (15046260) Jane Ooi (15046263) Anthony I. Skene (15046266) David A. Cameron (6277425) Judith M. Bliss (8827107)
author2_role	author author author author author author author author author author author author author author author author author author author author author author
author_facet	Nigel Bundred (15046233) Nuria Porta (15029895) Adrian Murray Brunt (15046236) Angela Cramer (5870894) Andrew Hanby (25460) Abeer M. Shaaban (15046239) Emad A. Rakha (7957955) Anne Armstrong (15045410) Ramsey I. Cutress (15046242) David Dodwell (15046245) Marie A. Emson (15046248) Abigail Evans (7421527) Sue M. Hartup (15046251) Kieran Horgan (15030513) Sarah E. Miller (15046254) Stuart A. McIntosh (11368948) James P. Morden (7594370) Jay Naik (15046257) Sankaran Narayanan (15046260) Jane Ooi (15046263) Anthony I. Skene (15046266) David A. Cameron (6277425) Judith M. Bliss (8827107)
author_role	author
dc.creator.none.fl_str_mv	Nigel Bundred (15046233) Nuria Porta (15029895) Adrian Murray Brunt (15046236) Angela Cramer (5870894) Andrew Hanby (25460) Abeer M. Shaaban (15046239) Emad A. Rakha (7957955) Anne Armstrong (15045410) Ramsey I. Cutress (15046242) David Dodwell (15046245) Marie A. Emson (15046248) Abigail Evans (7421527) Sue M. Hartup (15046251) Kieran Horgan (15030513) Sarah E. Miller (15046254) Stuart A. McIntosh (11368948) James P. Morden (7594370) Jay Naik (15046257) Sankaran Narayanan (15046260) Jane Ooi (15046263) Anthony I. Skene (15046266) David A. Cameron (6277425) Judith M. Bliss (8827107)
dc.date.none.fl_str_mv	2025-11-25T12:03:18Z
dc.identifier.none.fl_str_mv	10.1158/1078-0432.30705307
dc.relation.none.fl_str_mv	https://figshare.com/articles/dataset/Table_1_from_Combined_Perioperative_Lapatinib_and_Trastuzumab_in_Early_HER2-Positive_Breast_Cancer_Identifies_Early_Responders_Randomized_UK_EPHOS-B_Trial_Long-Term_Results/30705307
dc.rights.none.fl_str_mv	CC BY info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv	Cancer Cancer Detection and Diagnosis Clinical Research and Trials Biomarkers Prognostic biomarkers Breast Cancer Clinical Trial Results Phase II clinical trials Precision Medicine
dc.title.none.fl_str_mv	Table 1 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
dc.type.none.fl_str_mv	Dataset info:eu-repo/semantics/publishedVersion dataset
description	<p>Patient demographics and tumor characteristics at baseline and at surgery, by randomized treatment group.</p>
eu_rights_str_mv	openAccess
id	Manara_c49557a7c08ec8f354ea98eae1cc68a5
identifier_str_mv	10.1158/1078-0432.30705307
network_acronym_str	Manara
network_name_str	ManaraRepo
oai_identifier_str	oai:figshare.com:article/30705307
publishDate	2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv	CC BY
spelling	Table 1 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term ResultsNigel Bundred (15046233)Nuria Porta (15029895)Adrian Murray Brunt (15046236)Angela Cramer (5870894)Andrew Hanby (25460)Abeer M. Shaaban (15046239)Emad A. Rakha (7957955)Anne Armstrong (15045410)Ramsey I. Cutress (15046242)David Dodwell (15046245)Marie A. Emson (15046248)Abigail Evans (7421527)Sue M. Hartup (15046251)Kieran Horgan (15030513)Sarah E. Miller (15046254)Stuart A. McIntosh (11368948)James P. Morden (7594370)Jay Naik (15046257)Sankaran Narayanan (15046260)Jane Ooi (15046263)Anthony I. Skene (15046266)David A. Cameron (6277425)Judith M. Bliss (8827107)CancerCancer Detection and DiagnosisClinical Research and TrialsBiomarkersPrognostic biomarkersBreast CancerClinical Trial ResultsPhase II clinical trialsPrecision Medicine<p>Patient demographics and tumor characteristics at baseline and at surgery, by randomized treatment group.</p>2025-11-25T12:03:18ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30705307https://figshare.com/articles/dataset/Table_1_from_Combined_Perioperative_Lapatinib_and_Trastuzumab_in_Early_HER2-Positive_Breast_Cancer_Identifies_Early_Responders_Randomized_UK_EPHOS-B_Trial_Long-Term_Results/30705307CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307053072025-11-25T12:03:18Z
spellingShingle	Table 1 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results Nigel Bundred (15046233) Cancer Cancer Detection and Diagnosis Clinical Research and Trials Biomarkers Prognostic biomarkers Breast Cancer Clinical Trial Results Phase II clinical trials Precision Medicine
status_str	publishedVersion
title	Table 1 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
title_full	Table 1 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
title_fullStr	Table 1 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
title_full_unstemmed	Table 1 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
title_short	Table 1 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
title_sort	Table 1 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
topic	Cancer Cancer Detection and Diagnosis Clinical Research and Trials Biomarkers Prognostic biomarkers Breast Cancer Clinical Trial Results Phase II clinical trials Precision Medicine

Table 1 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results

Similar Items